New biologic works against synthetic opioid carfentanil (IMAGE)
Caption
A biologic (abzyme) developed by Scripps chemists converts the ultra-potent opioid carfentanil (left) to a weaker version (right) by stabilizing the reaction's transition-state (center). Utilizing abzymes could lead to new ways for treating synthetic opioid overdose.
Credit
Kim Janda, PhD, Scripps Research
Usage Restrictions
With related coverage and credit
License
Original content